Fulgent Genetics, Inc. (FLGT) — Financial statements
Income statement, balance sheet, and cash flow for Fulgent Genetics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 323↑13.8% | 283↓2.0% | 289↓53.3% | 619↓37.6% | 993 | |
| Cost of Revenue | 192↑8.8% | 176↓4.6% | 185↓26.7% | 252↑17.0% | 216 | |
| Gross Profit | 131↑22.1% | 107↑2.6% | 104↓71.5% | 367↓52.8% | 777 | |
| Operating Expenses | ||||||
| R&D Expenses | 54↑10.4% | 49↑17.8% | 41↑43.3% | 29↑19.4% | 24 | |
| General & Administrative Expenses | 117↑32.4% | 88↓1.0% | 89↓19.9% | 111↑118.9% | 51 | |
| Selling & Marketing Expenses | 43↑19.7% | 36↓12.6% | 41↑6.5% | 39↑59.2% | 24 | |
| SG&A Expenses | 160↑28.7% | 124↓4.7% | 130↓13.0% | 150↑99.5% | 75 | |
| Other Expenses | 8↑0.8% | 8↓93.8% | 128↑1252.2% | 9↑454.6% | 2 | |
| Operating Expenses | 222↑22.5% | 181↓39.6% | 300↑59.2% | 188↑86.3% | 101 | |
| Total Costs & Expenses | 414↑15.8% | 357↓26.3% | 485↑10.1% | 440↑39.1% | 317 | |
| Operating Results | ||||||
| Operating Income | -91↓23.2% | -74↑62.2% | -196↓209.5% | 179↓73.6% | 676 | |
| Depreciation & Amortization | 24↓3.2% | 25↓4.6% | 26↓20.0% | 33↑196.8% | 11 | |
| EBITDA | -46↑6.5% | -49↑66.8% | -147↓167.7% | 218↓68.3% | 687 | |
| EBIT | -70↑5.4% | -74↑57.4% | -174↓193.8% | 185↓72.6% | 676 | |
| Interest & Other Income | ||||||
| Net Interest Income | 31↓0.9% | 31↑47.4% | 21↑358.1% | 5↑242.3% | 1 | |
| Interest Income | 31↓1.2% | 31↑44.8% | 22↑284.3% | 6↑317.5% | 1 | |
| Interest Expense | 0.08↓55.9% | 0.17↓65.2% | 0.49↓51.8% | 1 | 0.00 | |
| Non-Operating Income | -21 | 0.00↑100.0% | -22↓236.8% | -7 | 0.00 | |
| Other Income / Expenses | 21↓4.1% | 22↑2.4% | 21↑290.0% | 5↑8.2% | 5 | |
| Income Before Tax | -70↓34.8% | -52↑70.2% | -174↓194.6% | 184↓73.0% | 681 | |
| Income Tax Expense | -8↓3.2% | -8↓805.0% | 1↓97.3% | 42↓75.9% | 175 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -62↓40.6% | -44↑75.0% | -175↓223.5% | 142↓72.0% | 506 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -61↓41.7% | -43↑74.6% | -168↓217.0% | 143↓71.7% | 507 | |
| Bottom-Line Net Income | -61↓41.7% | -43↑74.6% | -168↓217.0% | 143↓71.7% | 507 | |
| EPS (Basic) | -1.97↓39.7% | -1.41↑75.0% | -5.63↓218.3% | 4.76↓72.2% | 17.13 | |
| EPS (Diluted) | -1.97↓39.7% | -1.41↑75.0% | -5.63↓221.6% | 4.63↓71.5% | 16.26 | |
| Weighted Average Shares | 31↑1.8% | 30↑1.5% | 30↓1.0% | 30↑2.3% | 29 | |
| Weighted Average Diluted Shares | 31↑1.8% | 30↑1.5% | 30↓3.8% | 31↓0.0% | 31 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.